Help:Needs review/Stale reviews

This is a list of all content pages that are marked reviewed, but after the review it was subsequently edited. Presumably these pages need to be reviewed again.

1531 reviews are up to date. 887 reviews are stale and are listed below.

• The gut microbiota in conventional and serrated precursors of colorectal cancer
• The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 1
• The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 2
• The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 3
• The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 4
• The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 5
• The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 6
• The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 7
• Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas
• Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas/Experiment 1
• Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas/Experiment 2
• Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas/Experiment 3
• Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations
• Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations/Experiment 1
• Gut microbiome alterations in patients with stage 4 hepatitis C
• Gut microbiome alterations in patients with stage 4 hepatitis C/Experiment 1
• The lung microbiome in moderate and severe chronic obstructive pulmonary disease
• The lung microbiome in moderate and severe chronic obstructive pulmonary disease/Experiment 1
• The lung microbiome in moderate and severe chronic obstructive pulmonary disease/Experiment 2
• Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease
• Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease/Experiment 1
• Pyrosequencing study of fecal microflora of autistic and control children
• Pyrosequencing study of fecal microflora of autistic and control children/Experiment 1
• Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults
• Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults/Experiment 1
• A comprehensive analysis of breast cancer microbiota and host gene expression
• A comprehensive analysis of breast cancer microbiota and host gene expression/Experiment 1
• Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions
• Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions/Experiment 1
• Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions/Experiment 2
• Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions
• Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions/Experiment 1
• Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: a longitudinal study
• Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: a longitudinal study/Experiment 1
• Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: a longitudinal study/Experiment 2
• Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: a longitudinal study/Experiment 3
• Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: a longitudinal study/Experiment 4
• The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia
• The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia/Experiment 1
• The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia/Experiment 2
• The tongue microbiome in healthy subjects and patients with intra-oral halitosis
• The tongue microbiome in healthy subjects and patients with intra-oral halitosis/Experiment 1
• The Placental Microbiota Is Altered among Subjects with Gestational Diabetes Mellitus: A Pilot Study
• The Placental Microbiota Is Altered among Subjects with Gestational Diabetes Mellitus: A Pilot Study/Experiment 1
• Melatonin prevents obesity through modulation of gut microbiota in mice
• Melatonin prevents obesity through modulation of gut microbiota in mice/Experiment 1
• Melatonin prevents obesity through modulation of gut microbiota in mice/Experiment 2
• Altered gut microbiota profile in patients with generalized anxiety disorder
• Altered gut microbiota profile in patients with generalized anxiety disorder/Experiment 1
• Altered gut microbiota profile in patients with generalized anxiety disorder/Experiment 2
• High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice
• High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice/Experiment 1
• High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice/Experiment 2
• High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice/Experiment 3
• High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice/Experiment 3/Signature 2
• Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional study
• Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional study/Experiment 1
• The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
• The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota/Experiment 1
• The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota/Experiment 2
• 16S gut community of the Cameron County Hispanic Cohort
• 16S gut community of the Cameron County Hispanic Cohort/Experiment 1
• Analysis of Gut Microbiota in Patients with Parkinson's Disease
• Analysis of Gut Microbiota in Patients with Parkinson's Disease/Experiment 1
• Gut microbiome alterations in Alzheimer's disease
• Gut microbiome alterations in Alzheimer's disease/Experiment 1
• Gut microbiome alterations in Alzheimer's disease/Experiment 1/Signature 1
• Gut microbiome alterations in Alzheimer's disease/Experiment 1/Signature 2
• Chronic fatigue syndrome patients have alterations in their oral microbiome composition and function
• Chronic fatigue syndrome patients have alterations in their oral microbiome composition and function/Experiment 1
• Microbiome dynamics of human epidermis following skin barrier disruption
• Microbiome dynamics of human epidermis following skin barrier disruption/Experiment 1
• Intestinal Microbiota Is Influenced by Gender and Body Mass Index
• Intestinal Microbiota Is Influenced by Gender and Body Mass Index/Experiment 1
• Intestinal Microbiota Is Influenced by Gender and Body Mass Index/Experiment 2
• Maternal omega-3 fatty acids regulate offspring obesity through persistent modulation of gut microbiota
• Maternal omega-3 fatty acids regulate offspring obesity through persistent modulation of gut microbiota/Experiment 1
• Maternal omega-3 fatty acids regulate offspring obesity through persistent modulation of gut microbiota/Experiment 2
• Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome
• Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 1
• Altered fecal microbiota composition in patients with major depressive disorder
• Altered fecal microbiota composition in patients with major depressive disorder/Experiment 1
• Altered fecal microbiota composition in patients with major depressive disorder/Experiment 2
• High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients
• High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 1
• High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 2
• High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 3
• Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome
• Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 1
• Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 1/Signature 2
• Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 2
• Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 2/Signature 2
• Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 3
• Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 3/Signature 1
• Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests
• Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests/Experiment 1
• Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing
• Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing/Experiment 1
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 1
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 2
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 3
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 4
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 5
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 6
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 7
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 8
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 9
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 10
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 11
• Molecular analysis of oral microflora in patients with primary Sjögren's syndrome by using high-throughput sequencing
• Molecular analysis of oral microflora in patients with primary Sjögren's syndrome by using high-throughput sequencing/Experiment 1
• Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns
• Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns/Experiment 1
• Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns/Experiment 2
• Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns/Experiment 3
• Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns/Experiment 4
• Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns/Experiment 5
• Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns/Experiment 6
• Dysbiosis signature of fecal microbiota in colorectal cancer patients
• Dysbiosis signature of fecal microbiota in colorectal cancer patients/Experiment 1
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 1
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 2
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 3
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 1
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 2
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 3
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 4
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 5
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 6
• Gut microbiome in ADHD and its relation to neural reward anticipation
• Gut microbiome in ADHD and its relation to neural reward anticipation/Experiment 1
• Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response
• Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response/Experiment 1
• Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response/Experiment 1/Signature 2
• Alterations of Gut Microbiota in Cholestatic Infants and Their Correlation With Hepatic Function
• Alterations of Gut Microbiota in Cholestatic Infants and Their Correlation With Hepatic Function/Experiment 1
• Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behçet's disease
• Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behçet's disease/Experiment 1
• Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behçet's disease/Experiment 2
• Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations
• Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations/Experiment 1
• An intermittent hypercaloric diet alters gut microbiota, prefrontal cortical gene expression and social behaviours in rats
• An intermittent hypercaloric diet alters gut microbiota, prefrontal cortical gene expression and social behaviours in rats/Experiment 1
• Relative Abundance in Bacterial and Fungal Gut Microbes in Obese Children: A Case Control Study
• Relative Abundance in Bacterial and Fungal Gut Microbes in Obese Children: A Case Control Study/Experiment 1
• Diet, physical activity and screen time but not body mass index are associated with the gut microbiome of a diverse cohort of college students living in university housing: a cross-sectional study
• Diet, physical activity and screen time but not body mass index are associated with the gut microbiome of a diverse cohort of college students living in university housing: a cross-sectional study/Experiment 1
• Diet, physical activity and screen time but not body mass index are associated with the gut microbiome of a diverse cohort of college students living in university housing: a cross-sectional study/Experiment 2
• Obesity Alters the Microbial Community Profile in Korean Adolescents
• Obesity Alters the Microbial Community Profile in Korean Adolescents/Experiment 1
• Obesity Alters the Microbial Community Profile in Korean Adolescents/Experiment 2
• Obesity Alters the Microbial Community Profile in Korean Adolescents/Experiment 3
• Obesity Alters the Microbial Community Profile in Korean Adolescents/Experiment 4
• Obesity Alters the Microbial Community Profile in Korean Adolescents/Experiment 5
• Obesity Alters the Microbial Community Profile in Korean Adolescents/Experiment 6
• Characterization of the salivary microbiome in people with obesity
• Characterization of the salivary microbiome in people with obesity/Experiment 1
• Characterization of the salivary microbiome in people with obesity/Experiment 1/Signature 1
• Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers
• Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers/Experiment 1
• Gut microbiota in patients after surgical treatment for colorectal cancer
• Gut microbiota in patients after surgical treatment for colorectal cancer/Experiment 1
• Gut microbiota in patients after surgical treatment for colorectal cancer/Experiment 2
• Bacterial Diversity of Intestinal Microbiota in Patients with Substance Use Disorders Revealed by 16S rRNA Gene Deep Sequencing
• Bacterial Diversity of Intestinal Microbiota in Patients with Substance Use Disorders Revealed by 16S rRNA Gene Deep Sequencing/Experiment 1
• Bacterial Diversity of Intestinal Microbiota in Patients with Substance Use Disorders Revealed by 16S rRNA Gene Deep Sequencing/Experiment 2
• Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
• Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)/Experiment 1
• Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid
• Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid/Experiment 1
• Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid/Experiment 2
• Gut microbiota composition is correlated to grid floor induced stress and behavior in the BALB/c mouse
• Gut microbiota composition is correlated to grid floor induced stress and behavior in the BALB/c mouse/Experiment 1
• Diversified microbiota of meconium is affected by maternal diabetes status
• Diversified microbiota of meconium is affected by maternal diabetes status/Experiment 1
• Diversified microbiota of meconium is affected by maternal diabetes status/Experiment 2
• Diversified microbiota of meconium is affected by maternal diabetes status/Experiment 3
• The microbiome of the oral mucosa in irritable bowel syndrome
• The microbiome of the oral mucosa in irritable bowel syndrome/Experiment 1
• The microbiome of the oral mucosa in irritable bowel syndrome/Experiment 2
• The early infant gut microbiome varies in association with a maternal high-fat diet
• The early infant gut microbiome varies in association with a maternal high-fat diet/Experiment 1
• The early infant gut microbiome varies in association with a maternal high-fat diet/Experiment 2
• Exposure to Titanium Dioxide Nanoparticles During Pregnancy Changed Maternal Gut Microbiota and Increased Blood Glucose of Rat
• Exposure to Titanium Dioxide Nanoparticles During Pregnancy Changed Maternal Gut Microbiota and Increased Blood Glucose of Rat/Experiment 1
• Association between blood microbiome and type 2 diabetes mellitus: A nested case-control study
• Association between blood microbiome and type 2 diabetes mellitus: A nested case-control study/Experiment 1
• Association between blood microbiome and type 2 diabetes mellitus: A nested case-control study/Experiment 2
• Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy
• Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy/Experiment 1
• Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy/Experiment 2
• Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy/Experiment 3
• Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy/Experiment 4
• Sensitive Quantitative Analysis of the Meconium Bacterial Microbiota in Healthy Term Infants Born Vaginally or by Cesarean Section
• Sensitive Quantitative Analysis of the Meconium Bacterial Microbiota in Healthy Term Infants Born Vaginally or by Cesarean Section/Experiment 1
• Sensitive Quantitative Analysis of the Meconium Bacterial Microbiota in Healthy Term Infants Born Vaginally or by Cesarean Section
• Sensitive Quantitative Analysis of the Meconium Bacterial Microbiota in Healthy Term Infants Born Vaginally or by Cesarean Section/Experiment 1
• Sensitive Quantitative Analysis of the Meconium Bacterial Microbiota in Healthy Term Infants Born Vaginally or by Cesarean Section/Experiment 2
• Sensitive Quantitative Analysis of the Meconium Bacterial Microbiota in Healthy Term Infants Born Vaginally or by Cesarean Section/Experiment 3
• Investigation of the effect of type 2 diabetes mellitus on subgingival plaque microbiota by high-throughput 16S rDNA pyrosequencing
• Investigation of the effect of type 2 diabetes mellitus on subgingival plaque microbiota by high-throughput 16S rDNA pyrosequencing/Experiment 1
• Investigation of the effect of type 2 diabetes mellitus on subgingival plaque microbiota by high-throughput 16S rDNA pyrosequencing/Experiment 2
• Investigation of the effect of type 2 diabetes mellitus on subgingival plaque microbiota by high-throughput 16S rDNA pyrosequencing/Experiment 3
• Investigation of the effect of type 2 diabetes mellitus on subgingival plaque microbiota by high-throughput 16S rDNA pyrosequencing/Experiment 4
• Investigation of the effect of type 2 diabetes mellitus on subgingival plaque microbiota by high-throughput 16S rDNA pyrosequencing/Experiment 5
• Subgingival biodiversity in subjects with uncontrolled type-2 diabetes and chronic periodontitis
• Subgingival biodiversity in subjects with uncontrolled type-2 diabetes and chronic periodontitis/Experiment 1
• Meconium microbiome associates with the development of neonatal jaundice
• Meconium microbiome associates with the development of neonatal jaundice/Experiment 1
• Meconium microbiome associates with the development of neonatal jaundice/Experiment 2
• New evidences on the altered gut microbiota in autism spectrum disorders
• New evidences on the altered gut microbiota in autism spectrum disorders/Experiment 1
• New evidences on the altered gut microbiota in autism spectrum disorders/Experiment 2
• New evidences on the altered gut microbiota in autism spectrum disorders/Experiment 3
• New evidences on the altered gut microbiota in autism spectrum disorders/Experiment 4
• A taxonomic signature of obesity in a large study of American adults
• A taxonomic signature of obesity in a large study of American adults/Experiment 2
• A taxonomic signature of obesity in a large study of American adults/Experiment 3
• A taxonomic signature of obesity in a large study of American adults/Experiment 4
• A taxonomic signature of obesity in a large study of American adults/Experiment 5
• A taxonomic signature of obesity in a large study of American adults/Experiment 6
• Body Mass Index Differences in the Gut Microbiota Are Gender Specific
• Body Mass Index Differences in the Gut Microbiota Are Gender Specific/Experiment 1
• Body Mass Index Differences in the Gut Microbiota Are Gender Specific/Experiment 2
• Body Mass Index Differences in the Gut Microbiota Are Gender Specific/Experiment 3
• Body Mass Index Differences in the Gut Microbiota Are Gender Specific/Experiment 4
• Composition of gut microbiota in obese and normal-weight Mexican school-age children and its association with metabolic traits
• Composition of gut microbiota in obese and normal-weight Mexican school-age children and its association with metabolic traits/Experiment 1
• Composition of gut microbiota in obese and normal-weight Mexican school-age children and its association with metabolic traits/Experiment 2
• Composition of gut microbiota in obese and normal-weight Mexican school-age children and its association with metabolic traits/Experiment 3
• Meconium microbiome analysis identifies bacteria correlated with premature birth
• Meconium microbiome analysis identifies bacteria correlated with premature birth/Experiment 1
• Meconium microbiome analysis identifies bacteria correlated with premature birth/Experiment 2
• Analysis of gut microbiota profiles and microbe-disease associations in children with autism spectrum disorders in China
• Analysis of gut microbiota profiles and microbe-disease associations in children with autism spectrum disorders in China/Experiment 1
• Gut Microbiota and Predicted Metabolic Pathways in a Sample of Mexican Women Affected by Obesity and Obesity Plus Metabolic Syndrome
• Gut Microbiota and Predicted Metabolic Pathways in a Sample of Mexican Women Affected by Obesity and Obesity Plus Metabolic Syndrome/Experiment 1
• Gut Microbiota and Predicted Metabolic Pathways in a Sample of Mexican Women Affected by Obesity and Obesity Plus Metabolic Syndrome/Experiment 2
• Human intestinal microbiota composition is associated with local and systemic inflammation in obesity
• Human intestinal microbiota composition is associated with local and systemic inflammation in obesity/Experiment 1
• Human intestinal microbiota composition is associated with local and systemic inflammation in obesity/Experiment 2
• Human intestinal microbiota composition is associated with local and systemic inflammation in obesity/Experiment 3
• Human intestinal microbiota composition is associated with local and systemic inflammation in obesity/Experiment 4
• Disordered microbial communities in the upper respiratory tract of cigarette smokers
• Disordered microbial communities in the upper respiratory tract of cigarette smokers/Experiment 1
• Disordered microbial communities in the upper respiratory tract of cigarette smokers/Experiment 2
• Disordered microbial communities in the upper respiratory tract of cigarette smokers/Experiment 3
• Disordered microbial communities in the upper respiratory tract of cigarette smokers/Experiment 4
• Imbalance of Fecal Microbiota at Newly Diagnosed Type 1 Diabetes in Chinese Children
• Imbalance of Fecal Microbiota at Newly Diagnosed Type 1 Diabetes in Chinese Children/Experiment 1
• Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort
• Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort/Experiment 1
• Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption
• Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption/Experiment 1
• Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption/Experiment 2
• Fecal microbiota imbalance in Mexican children with type 1 diabetes
• Fecal microbiota imbalance in Mexican children with type 1 diabetes/Experiment 1
• Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota
• Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota/Experiment 1
• Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota/Experiment 2
• Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters
• Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters/Experiment 1
• Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters
• Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters/Experiment 1
• Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters
• Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters/Experiment 1
• Evolution in fecal bacterial/viral composition in infants of two central African countries (Gabon and Republic of the Congo) during their first month of life
• Evolution in fecal bacterial/viral composition in infants of two central African countries (Gabon and Republic of the Congo) during their first month of life/Experiment 1
• Evolution in fecal bacterial/viral composition in infants of two central African countries (Gabon and Republic of the Congo) during their first month of life/Experiment 2
• Evolution in fecal bacterial/viral composition in infants of two central African countries (Gabon and Republic of the Congo) during their first month of life/Experiment 3
• Evolution in fecal bacterial/viral composition in infants of two central African countries (Gabon and Republic of the Congo) during their first month of life/Experiment 4
• Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life
• Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life/Experiment 1
• Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life/Experiment 2
• Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life/Experiment 3
• Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life/Experiment 4
• Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life/Experiment 5
• Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life/Experiment 6
• Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life/Experiment 7
• Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life/Experiment 8
• Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study
• Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study/Experiment 1
• Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study/Experiment 2
• Delivery Mode and the Transition of Pioneering Gut-Microbiota Structure, Composition and Predicted Metabolic Function
• Delivery Mode and the Transition of Pioneering Gut-Microbiota Structure, Composition and Predicted Metabolic Function/Experiment 1
• Delivery Mode and the Transition of Pioneering Gut-Microbiota Structure, Composition and Predicted Metabolic Function
• Delivery Mode and the Transition of Pioneering Gut-Microbiota Structure, Composition and Predicted Metabolic Function/Experiment 1
• Delivery Mode and the Transition of Pioneering Gut-Microbiota Structure, Composition and Predicted Metabolic Function/Experiment 2
• Initial meconium microbiome in Chinese neonates delivered naturally or by cesarean section
• Initial meconium microbiome in Chinese neonates delivered naturally or by cesarean section/Experiment 1
• Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease
• Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease/Experiment 1
• Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease/Experiment 2
• Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease/Experiment 3
• Maternal influence on the fetal microbiome in a population-based study of the first-pass meconium
• Maternal influence on the fetal microbiome in a population-based study of the first-pass meconium/Experiment 1
• Maternal influence on the fetal microbiome in a population-based study of the first-pass meconium/Experiment 2
• Maternal influence on the fetal microbiome in a population-based study of the first-pass meconium/Experiment 3
• Maternal influence on the fetal microbiome in a population-based study of the first-pass meconium/Experiment 4
• Characterization of the Gut Microbial Community of Obese Patients Following a Weight-Loss Intervention Using Whole Metagenome Shotgun Sequencing
• Characterization of the Gut Microbial Community of Obese Patients Following a Weight-Loss Intervention Using Whole Metagenome Shotgun Sequencing/Experiment 1
• Characterization of the Gut Microbial Community of Obese Patients Following a Weight-Loss Intervention Using Whole Metagenome Shotgun Sequencing/Experiment 2
• Characterization of the Gut Microbial Community of Obese Patients Following a Weight-Loss Intervention Using Whole Metagenome Shotgun Sequencing/Experiment 3
• Gut microbiota and overweight in 3-year old children
• Gut microbiota and overweight in 3-year old children/Experiment 1
• Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population
• Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population/Experiment 1
• Differential composition of gut microbiota among healthy volunteers, morbidly obese patients and post-bariatric surgery patients
• Differential composition of gut microbiota among healthy volunteers, morbidly obese patients and post-bariatric surgery patients/Experiment 1
• Differential composition of gut microbiota among healthy volunteers, morbidly obese patients and post-bariatric surgery patients/Experiment 2
• Differential composition of gut microbiota among healthy volunteers, morbidly obese patients and post-bariatric surgery patients/Experiment 3
• Differential composition of gut microbiota among healthy volunteers, morbidly obese patients and post-bariatric surgery patients/Experiment 4
• Blood Microbiome Profile in CKD : A Pilot Study
• Blood Microbiome Profile in CKD : A Pilot Study/Experiment 1
• Blood Microbiome Profile in CKD : A Pilot Study/Experiment 1/Signature 1
• Blood Microbiome Profile in CKD : A Pilot Study/Experiment 1/Signature 2
• Gut Microbiota in Patients with Different Metabolic Statuses: Moscow Study
• Gut Microbiota in Patients with Different Metabolic Statuses: Moscow Study/Experiment 1
• Gut Microbiota in Patients with Different Metabolic Statuses: Moscow Study/Experiment 2
• Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii
• Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii/Experiment 1
• The stool microbiota of insulin resistant women with recent gestational diabetes, a high risk group for type 2 diabetes
• The stool microbiota of insulin resistant women with recent gestational diabetes, a high risk group for type 2 diabetes/Experiment 1
• Sex differences in gut microbiota in patients with major depressive disorder
• Sex differences in gut microbiota in patients with major depressive disorder/Experiment 1
• Sex differences in gut microbiota in patients with major depressive disorder/Experiment 2
• Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder
• Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder/Experiment 1
• Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder/Experiment 2
• Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder/Experiment 3
• Weight gain in anorexia nervosa does not ameliorate the faecal microbiota, branched chain fatty acid profiles, and gastrointestinal complaints/Experiment 2/Signature 2
• Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study
• Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study/Experiment 1
• The Perturbation of Infant Gut Microbiota Caused by Cesarean Delivery Is Partially Restored by Exclusive Breastfeeding
• The Perturbation of Infant Gut Microbiota Caused by Cesarean Delivery Is Partially Restored by Exclusive Breastfeeding/Experiment 1
• The Perturbation of Infant Gut Microbiota Caused by Cesarean Delivery Is Partially Restored by Exclusive Breastfeeding/Experiment 2
• Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease
• Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease/Experiment 1
• Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease/Experiment 2
• Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease/Experiment 3
• Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levels
• Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levels/Experiment 1
• Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levels/Experiment 2
• Subgingival Microbiome of Gingivitis in Chinese Undergraduates
• Subgingival Microbiome of Gingivitis in Chinese Undergraduates/Experiment 1
• Subgingival Microbiome of Gingivitis in Chinese Undergraduates/Experiment 1/Signature 1
• High fat diet alters gut microbiota but not spatial working memory in early middle-aged Sprague Dawley rats
• High fat diet alters gut microbiota but not spatial working memory in early middle-aged Sprague Dawley rats/Experiment 1
• The combination of sport and sport-specific diet is associated with characteristics of gut microbiota: an observational study
• The combination of sport and sport-specific diet is associated with characteristics of gut microbiota: an observational study/Experiment 1
• The combination of sport and sport-specific diet is associated with characteristics of gut microbiota: an observational study/Experiment 2
• The combination of sport and sport-specific diet is associated with characteristics of gut microbiota: an observational study/Experiment 3
• Analysis of oral microbiota in Japanese oral cancer patients using 16S rRNA sequencing
• Analysis of oral microbiota in Japanese oral cancer patients using 16S rRNA sequencing/Experiment 1
• Changes in the salivary microbiota of oral leukoplakia and oral cancer
• Changes in the salivary microbiota of oral leukoplakia and oral cancer/Experiment 1
• Changes in the salivary microbiota of oral leukoplakia and oral cancer/Experiment 2
• Changes in the salivary microbiota of oral leukoplakia and oral cancer/Experiment 3
• Influence of food consumption patterns and Galician lifestyle on human gut microbiota
• Influence of food consumption patterns and Galician lifestyle on human gut microbiota/Experiment 1
• Influence of food consumption patterns and Galician lifestyle on human gut microbiota/Experiment 2
• Influence of food consumption patterns and Galician lifestyle on human gut microbiota/Experiment 3
• Influence of food consumption patterns and Galician lifestyle on human gut microbiota/Experiment 4
• Influence of food consumption patterns and Galician lifestyle on human gut microbiota/Experiment 5
• Influence of food consumption patterns and Galician lifestyle on human gut microbiota/Experiment 6
• Influence of food consumption patterns and Galician lifestyle on human gut microbiota/Experiment 7
• Influence of food consumption patterns and Galician lifestyle on human gut microbiota/Experiment 8
• Daily Consumption of Orange Juice from Citrus sinensis L. Osbeck cv. Cara Cara and cv. Bahia Differently Affects Gut Microbiota Profiling as Unveiled by an Integrated Meta-Omics Approach
• Daily Consumption of Orange Juice from Citrus sinensis L. Osbeck cv. Cara Cara and cv. Bahia Differently Affects Gut Microbiota Profiling as Unveiled by an Integrated Meta-Omics Approach/Experiment 1
• Daily Consumption of Orange Juice from Citrus sinensis L. Osbeck cv. Cara Cara and cv. Bahia Differently Affects Gut Microbiota Profiling as Unveiled by an Integrated Meta-Omics Approach/Experiment 2
• Daily Consumption of Orange Juice from Citrus sinensis L. Osbeck cv. Cara Cara and cv. Bahia Differently Affects Gut Microbiota Profiling as Unveiled by an Integrated Meta-Omics Approach/Experiment 3
• Daily Consumption of Orange Juice from Citrus sinensis L. Osbeck cv. Cara Cara and cv. Bahia Differently Affects Gut Microbiota Profiling as Unveiled by an Integrated Meta-Omics Approach/Experiment 4
• Daily Consumption of Orange Juice from Citrus sinensis L. Osbeck cv. Cara Cara and cv. Bahia Differently Affects Gut Microbiota Profiling as Unveiled by an Integrated Meta-Omics Approach/Experiment 5
• Daily Consumption of Orange Juice from Citrus sinensis L. Osbeck cv. Cara Cara and cv. Bahia Differently Affects Gut Microbiota Profiling as Unveiled by an Integrated Meta-Omics Approach/Experiment 6
• Impact of Agaricus bisporus Mushroom Consumption on Gut Health Markers in Healthy Adults
• Impact of Agaricus bisporus Mushroom Consumption on Gut Health Markers in Healthy Adults/Experiment 1
• Microbial enterotypes, inferred by the prevotella-to-bacteroides ratio, remained stable during a 6-month randomized controlled diet intervention with the new nordic diet
• Microbial enterotypes, inferred by the prevotella-to-bacteroides ratio, remained stable during a 6-month randomized controlled diet intervention with the new nordic diet/Experiment 1
• Microbial enterotypes, inferred by the prevotella-to-bacteroides ratio, remained stable during a 6-month randomized controlled diet intervention with the new nordic diet/Experiment 2
• Microbiome Responses to an Uncontrolled Short-Term Diet Intervention in the Frame of the Citizen Science Project
• Microbiome Responses to an Uncontrolled Short-Term Diet Intervention in the Frame of the Citizen Science Project/Experiment 2
• Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer
• Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer/Experiment 1
• Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer/Experiment 1/Signature 1
• Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer/Experiment 1/Signature 2
• Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer/Experiment 2
• Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer/Experiment 2/Signature 1
• Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer/Experiment 3
• Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer/Experiment 3/Signature 1
• Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer/Experiment 4
• Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer/Experiment 4/Signature 1
• Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer/Experiment 4/Signature 2
• Alterations of the human gut microbiome in multiple sclerosis/Experiment 1
• Alterations of the human gut microbiome in multiple sclerosis/Experiment 2
• Alterations of the human gut microbiome in multiple sclerosis/Experiment 5
• Alterations of the human gut microbiome in multiple sclerosis/Experiment 6
• 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment
• 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment/Experiment 1
• 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment/Experiment 2
• 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment/Experiment 3
• The Human Mesenteric Lymph Node Microbiome Differentiates Between Crohn's Disease and Ulcerative Colitis
• The Human Mesenteric Lymph Node Microbiome Differentiates Between Crohn's Disease and Ulcerative Colitis/Experiment 1
• The Human Mesenteric Lymph Node Microbiome Differentiates Between Crohn's Disease and Ulcerative Colitis/Experiment 2
• Air pollution during the winter period and respiratory tract microbial imbalance in a healthy young population in Northeastern China
• Air pollution during the winter period and respiratory tract microbial imbalance in a healthy young population in Northeastern China/Experiment 1
• Air pollution during the winter period and respiratory tract microbial imbalance in a healthy young population in Northeastern China/Experiment 2
• Air pollution during the winter period and respiratory tract microbial imbalance in a healthy young population in Northeastern China/Experiment 3
• The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects
• The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects/Experiment 1
• Variations in oral microbiota associated with oral cancer
• Variations in oral microbiota associated with oral cancer/Experiment 1
• Microbiota in the Throat and Risk Factors for Laryngeal Carcinoma
• Microbiota in the Throat and Risk Factors for Laryngeal Carcinoma/Experiment 1
• Microbiota in the Throat and Risk Factors for Laryngeal Carcinoma/Experiment 2
• Variations in Oral Microbiota Composition Are Associated With a Risk of Throat Cancer
• Variations in Oral Microbiota Composition Are Associated With a Risk of Throat Cancer/Experiment 1
• Variations in Oral Microbiota Composition Are Associated With a Risk of Throat Cancer/Experiment 2
• Breast cancer in postmenopausal women is associated with an altered gut metagenome
• Breast cancer in postmenopausal women is associated with an altered gut metagenome/Experiment 1
• Altered diversity and composition of the gut microbiome in patients with cervical cancer/Experiment 2
• Oral Microbiome Composition Reflects Prospective Risk for Esophageal Cancers
• Oral Microbiome Composition Reflects Prospective Risk for Esophageal Cancers/Experiment 1
• Oral Microbiome Composition Reflects Prospective Risk for Esophageal Cancers/Experiment 2
• Intestinal Microbiota Is Altered in Patients with Gastric Cancer from Shanxi Province, China
• Intestinal Microbiota Is Altered in Patients with Gastric Cancer from Shanxi Province, China/Experiment 1
• Intestinal Microbiota Is Altered in Patients with Gastric Cancer from Shanxi Province, China/Experiment 2
• Dysbiosis of the Gut Microbiome is associated with Tumor Biomarkers in Lung Cancer/Experiment 4
• Dysbiosis of the Gut Microbiome is associated with Tumor Biomarkers in Lung Cancer/Experiment 5
• Altered oral microbiota in chronic hepatitis B patients with different tongue coatings/Experiment 1
• Altered oral microbiota in chronic hepatitis B patients with different tongue coatings/Experiment 1/Signature 1
• Altered oral microbiota in chronic hepatitis B patients with different tongue coatings/Experiment 2
• Altered oral microbiota in chronic hepatitis B patients with different tongue coatings/Experiment 3
• Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects/Experiment 2
• Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects/Experiment 3
• Characteristics of the Salivary Microbiota in Patients With Various Digestive Tract Cancers/Experiment 3
• Characteristics of the Salivary Microbiota in Patients With Various Digestive Tract Cancers/Experiment 4
• Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention/Experiment 1
• Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention/Experiment 2
• Decreased Diversity of the Oral Microbiota of Patients with Hepatitis B Virus-Induced Chronic Liver Disease: A Pilot Project/Experiment 1
• Decreased Diversity of the Oral Microbiota of Patients with Hepatitis B Virus-Induced Chronic Liver Disease: A Pilot Project/Experiment 2
• Lower airway microbiota and mycobiota in children with severe asthma/Experiment 1
• The differential distribution of bacteria between cancerous and noncancerous ovarian tissues in situ/Experiment 1/Signature 1
• Autism Spectrum Disorder (ASD) with and without Mental Regression is Associated with Changes in the Fecal Microbiota/Experiment 1
• Autism Spectrum Disorder (ASD) with and without Mental Regression is Associated with Changes in the Fecal Microbiota/Experiment 2
• Increased Abundance of Clostridium and Fusobacterium in Gastric Microbiota of Patients with Gastric Cancer in Taiwan/Experiment 1
• Association of dietary fibre intake and gut microbiota in adults
• Association of dietary fibre intake and gut microbiota in adults/Experiment 1
• Early-Life Events, Including Mode of Delivery and Type of Feeding, Siblings and Gender, Shape the Developing Gut Microbiota/Experiment 1
• Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia/Experiment 1
• Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls
• Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls/Experiment 1
• Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls/Experiment 1/Signature 2
• Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls/Experiment 2
• Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls/Experiment 3
• Association Between Gut Microbiota and Helicobacter pylori-Related Gastric Lesions in a High-Risk Population of Gastric Cancer/Experiment 3/Signature 1
• The cervical microbiota in reproductive-age South African women with and without human papillomavirus infection
• The cervical microbiota in reproductive-age South African women with and without human papillomavirus infection/Experiment 1
• The cervical microbiota in reproductive-age South African women with and without human papillomavirus infection/Experiment 2
• The imbalance of gut microbiota and its correlation with plasma inflammatory cytokines in pemphigus vulgaris patients/Experiment 1
• Relationship between the Cervical Microbiome, HIV Status, and Precancerous Lesions
• Relationship between the Cervical Microbiome, HIV Status, and Precancerous Lesions/Experiment 1
• Relationship between the Cervical Microbiome, HIV Status, and Precancerous Lesions/Experiment 2
• Relationship between the Cervical Microbiome, HIV Status, and Precancerous Lesions/Experiment 3
• Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer/Experiment 9
• Emollient use alters skin barrier and microbes in infants at risk for developing atopic dermatitis/Experiment 1
• Differences in Gut Microbiota Profiles between Autoimmune Pancreatitis and Chronic Pancreatitis/Experiment 1
• Bacterial biogeography of adult airways in atopic asthma/Experiment 1
• Bacterial biogeography of adult airways in atopic asthma/Experiment 2
• Bacterial biogeography of adult airways in atopic asthma/Experiment 3
• Bacterial biogeography of adult airways in atopic asthma/Experiment 4
• Bacterial biogeography of adult airways in atopic asthma/Experiment 5
• Bacterial biogeography of adult airways in atopic asthma/Experiment 6
• Bacterial biogeography of adult airways in atopic asthma/Experiment 7
• A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?
• A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?/Experiment 1
• A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?/Experiment 1/Signature 1
• A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?/Experiment 2
• A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?/Experiment 3
• A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?/Experiment 4
• Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women
• Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women/Experiment 1
• Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment/Experiment 1
• Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment/Experiment 2
• Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment/Experiment 3
• Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment/Experiment 4
• Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment/Experiment 5
• Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment/Experiment 6
• Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment/Experiment 7
• Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment/Experiment 8
• Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment/Experiment 9
• Cervical microbiome is altered in cervical intraepithelial neoplasia after loop electrosurgical excision procedure in china
• Cervical microbiome is altered in cervical intraepithelial neoplasia after loop electrosurgical excision procedure in china/Experiment 1
• Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection
• Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection/Experiment 1
• Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection/Experiment 2
• Infectious Complications Are Associated With Alterations in the Gut Microbiome in Pediatric Patients With Acute Lymphoblastic Leukemia/Experiment 1
• Infectious Complications Are Associated With Alterations in the Gut Microbiome in Pediatric Patients With Acute Lymphoblastic Leukemia/Experiment 1/Signature 1
• Infectious Complications Are Associated With Alterations in the Gut Microbiome in Pediatric Patients With Acute Lymphoblastic Leukemia/Experiment 1/Signature 2
• Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women
• Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women/Experiment 1
• Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women/Experiment 2
• Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women/Experiment 3
• Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women/Experiment 4
• Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women/Experiment 5
• Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women/Experiment 6
• Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women/Experiment 7
• Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women/Experiment 7/Signature 2
• Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women/Experiment 8
• Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women/Experiment 9
• Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women/Experiment 10
• Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers/Experiment 1
• Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity
• Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity/Experiment 1
• The vaginal metabolome and microbiota of cervical HPV-positive and HPV-negative women: a cross-sectional analysis
• The vaginal metabolome and microbiota of cervical HPV-positive and HPV-negative women: a cross-sectional analysis/Experiment 1
• Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study
• Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study/Experiment 1
• Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study/Experiment 1/Signature 1
• Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study/Experiment 2
• Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study/Experiment 2/Signature 2
• Cervicovaginal microbiome and natural history of HPV in a longitudinal study
• Cervicovaginal microbiome and natural history of HPV in a longitudinal study/Experiment 1
• Cervicovaginal microbiome and natural history of HPV in a longitudinal study/Experiment 2
• Evaluation of the Associations Between Cervical Microbiota and HPV Infection, Clearance, and Persistence in Cytologically Normal Women
• Evaluation of the Associations Between Cervical Microbiota and HPV Infection, Clearance, and Persistence in Cytologically Normal Women/Experiment 1
• Evaluation of the Associations Between Cervical Microbiota and HPV Infection, Clearance, and Persistence in Cytologically Normal Women/Experiment 2
• Evaluation of the Associations Between Cervical Microbiota and HPV Infection, Clearance, and Persistence in Cytologically Normal Women/Experiment 3
• Evaluation of the Associations Between Cervical Microbiota and HPV Infection, Clearance, and Persistence in Cytologically Normal Women/Experiment 4
• Evaluation of the Associations Between Cervical Microbiota and HPV Infection, Clearance, and Persistence in Cytologically Normal Women/Experiment 5
• Evaluation of the Associations Between Cervical Microbiota and HPV Infection, Clearance, and Persistence in Cytologically Normal Women/Experiment 6
• Evaluation of the Associations Between Cervical Microbiota and HPV Infection, Clearance, and Persistence in Cytologically Normal Women/Experiment 7
• Patients With LR-HPV Infection Have a Distinct Vaginal Microbiota in Comparison With Healthy Controls
• Patients With LR-HPV Infection Have a Distinct Vaginal Microbiota in Comparison With Healthy Controls/Experiment 1
• Association between the vaginal microbiome and high-risk human papillomavirus infection in pregnant Chinese women
• Association between the vaginal microbiome and high-risk human papillomavirus infection in pregnant Chinese women/Experiment 1
• Association between the vaginal microbiome and high-risk human papillomavirus infection in pregnant Chinese women/Experiment 2
• Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients/Experiment 2
• Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: The impact of the gut microbiota/Experiment 1
• Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort
• Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort/Experiment 1
• Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort/Experiment 2
• Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort/Experiment 3
• The nasal microbiome in asthma
• The nasal microbiome in asthma/Experiment 3
• The nasal microbiome in asthma/Experiment 5
• Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial
• Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial/Experiment 1
• Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial/Experiment 1/Signature 1
• Cervical Microbiota Associated with Higher Grade Cervical Intraepithelial Neoplasia in Women Infected with High-Risk Human Papillomaviruses
• Cervical Microbiota Associated with Higher Grade Cervical Intraepithelial Neoplasia in Women Infected with High-Risk Human Papillomaviruses/Experiment 1
• Cervical Microbiota Associated with Higher Grade Cervical Intraepithelial Neoplasia in Women Infected with High-Risk Human Papillomaviruses/Experiment 2
• Cervical Microbiota Associated with Higher Grade Cervical Intraepithelial Neoplasia in Women Infected with High-Risk Human Papillomaviruses/Experiment 3
• The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions
• The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions/Experiment 1
• The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions/Experiment 2
• The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions/Experiment 3
• The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions/Experiment 4
• HPV infection and bacterial microbiota in the placenta, uterine cervix and oral mucosa
• HPV infection and bacterial microbiota in the placenta, uterine cervix and oral mucosa/Experiment 1
• HPV infection and bacterial microbiota in the placenta, uterine cervix and oral mucosa/Experiment 2
• HPV infection and bacterial microbiota in the placenta, uterine cervix and oral mucosa/Experiment 3
• Effects of One-Week Empirical Antibiotic Therapy on the Early Development of Gut Microbiota and Metabolites in Preterm Infants
• Alteration of the gut microbiota associated with childhood obesity by 16S rRNA gene sequencing/Experiment 1
• Alteration of the gut microbiota associated with childhood obesity by 16S rRNA gene sequencing/Experiment 2/Signature 2
• Ambient Ultrafine Particle Ingestion Alters Gut Microbiota in Association with Increased Atherogenic Lipid Metabolites/Experiment 1
• Distinct nasal airway bacterial microbiotas differentially relate to exacerbation in pediatric patients with asthma/Experiment 1
• Distinct nasal airway bacterial microbiotas differentially relate to exacerbation in pediatric patients with asthma/Experiment 2
• Distinct nasal airway bacterial microbiotas differentially relate to exacerbation in pediatric patients with asthma/Experiment 3
• Distinct nasal airway bacterial microbiotas differentially relate to exacerbation in pediatric patients with asthma/Experiment 5
• Distinct nasal airway bacterial microbiotas differentially relate to exacerbation in pediatric patients with asthma/Experiment 8
• A study of the correlation between obesity and intestinal flora in school-age children/Experiment 1
• Correlation between body mass index and faecal microbiota from children/Experiment 2
• Cervicovaginal Fungi and Bacteria Associated With Cervical Intraepithelial Neoplasia and High-Risk Human Papillomavirus Infections in a Hispanic Population
• Cervicovaginal Fungi and Bacteria Associated With Cervical Intraepithelial Neoplasia and High-Risk Human Papillomavirus Infections in a Hispanic Population/Experiment 1
• Cervicovaginal Fungi and Bacteria Associated With Cervical Intraepithelial Neoplasia and High-Risk Human Papillomavirus Infections in a Hispanic Population/Experiment 2
• Cervicovaginal Fungi and Bacteria Associated With Cervical Intraepithelial Neoplasia and High-Risk Human Papillomavirus Infections in a Hispanic Population/Experiment 3
• Cervicovaginal Fungi and Bacteria Associated With Cervical Intraepithelial Neoplasia and High-Risk Human Papillomavirus Infections in a Hispanic Population/Experiment 4
• High-Level PM2.5/PM10 Exposure Is Associated With Alterations in the Human Pharyngeal Microbiota Composition/Experiment 1
• Cigarette smoking and the oral microbiome in a large study of American adults/Experiment 1
• Effects of sex and chronic cigarette smoke exposure on the mouse cecal microbiome/Experiment 1
• Effects of sex and chronic cigarette smoke exposure on the mouse cecal microbiome/Experiment 2
• Effects of sex and chronic cigarette smoke exposure on the mouse cecal microbiome/Experiment 2/Signature 1
• Effects of sex and chronic cigarette smoke exposure on the mouse cecal microbiome/Experiment 3
• Effects of sex and chronic cigarette smoke exposure on the mouse cecal microbiome/Experiment 4
• A Metabologenomic Approach Reveals Changes in the Intestinal Environment of Mice Fed on American Diet/Experiment 1
• A Metabologenomic Approach Reveals Changes in the Intestinal Environment of Mice Fed on American Diet/Experiment 1/Signature 1
• Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli/Experiment 1
• Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli/Experiment 2
• Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli/Experiment 3
• Compositional and Functional Differences between Microbiota and Cervical Carcinogenesis as Identified by Shotgun Metagenomic Sequencing/Experiment 1
• Compositional and Functional Differences between Microbiota and Cervical Carcinogenesis as Identified by Shotgun Metagenomic Sequencing/Experiment 2
• Electronic Cigarette Aerosol Modulates the Oral Microbiome and Increases Risk of Infection
• Electronic Cigarette Aerosol Modulates the Oral Microbiome and Increases Risk of Infection/Experiment 1
• Electronic Cigarette Aerosol Modulates the Oral Microbiome and Increases Risk of Infection/Experiment 2
• Electronic Cigarette Aerosol Modulates the Oral Microbiome and Increases Risk of Infection/Experiment 3
• Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity/Experiment 1
• Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity/Experiment 1/Signature 2
• Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity
• Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity/Experiment 1
• Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity/Experiment 2
• Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity/Experiment 3
• Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity/Experiment 4
• Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study
• Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study/Experiment 1
• Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study/Experiment 2
• HPV/Chlamydia trachomatis co-infection: metagenomic analysis of cervical microbiota in asymptomatic women
• HPV/Chlamydia trachomatis co-infection: metagenomic analysis of cervical microbiota in asymptomatic women/Experiment 1
• HPV/Chlamydia trachomatis co-infection: metagenomic analysis of cervical microbiota in asymptomatic women/Experiment 2
• Infant airway microbiota and topical immune perturbations in the origins of childhood asthma/Experiment 1
• Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis/Experiment 1
• Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis/Experiment 2
• Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis/Experiment 3
• Airway Microbial Diversity is Inversely Associated with Mite-Sensitized Rhinitis and Asthma in Early Childhood/Experiment 1
• Airway Microbial Diversity is Inversely Associated with Mite-Sensitized Rhinitis and Asthma in Early Childhood/Experiment 2
• Variations in early gut microbiome are associated with childhood eczema
• Variations in early gut microbiome are associated with childhood eczema/Experiment 1
• Variations in early gut microbiome are associated with childhood eczema/Experiment 2
• Variations in early gut microbiome are associated with childhood eczema/Experiment 3
• Variations in early gut microbiome are associated with childhood eczema/Experiment 4
• Variations in early gut microbiome are associated with childhood eczema/Experiment 5
• Variations in early gut microbiome are associated with childhood eczema/Experiment 6
• Variations in early gut microbiome are associated with childhood eczema/Experiment 7
• Variations in early gut microbiome are associated with childhood eczema/Experiment 8
• Variations in early gut microbiome are associated with childhood eczema/Experiment 9
• Variations in early gut microbiome are associated with childhood eczema/Experiment 10
• Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis/Experiment 1
• Alterations to the Gastrointestinal Microbiome Associated with Methamphetamine Use among Young Men who have Sex with Men/Experiment 1
• Alterations to the Gastrointestinal Microbiome Associated with Methamphetamine Use among Young Men who have Sex with Men/Experiment 2
• Alterations to the Gastrointestinal Microbiome Associated with Methamphetamine Use among Young Men who have Sex with Men/Experiment 3
• Alterations to the Gastrointestinal Microbiome Associated with Methamphetamine Use among Young Men who have Sex with Men/Experiment 4
• Alterations to the Gastrointestinal Microbiome Associated with Methamphetamine Use among Young Men who have Sex with Men/Experiment 4/Signature 2
• The gut microbiome and inflammation in obsessive-compulsive disorder patients compared to age- and sex-matched controls: a pilot study/Experiment 1
• Gut microbiota and plasma metabolites associated with diabetes in women with, or at high risk for, HIV infection/Experiment 1
• Fecal microbiome signatures of pancreatic cancer patients/Experiment 4/Signature 2
• Distinct Features of Gut Microbiota in High-Altitude Tibetan and Middle-Altitude Han Hypertensive Patients
• Distinct Features of Gut Microbiota in High-Altitude Tibetan and Middle-Altitude Han Hypertensive Patients/Experiment 1
• Distinct Features of Gut Microbiota in High-Altitude Tibetan and Middle-Altitude Han Hypertensive Patients/Experiment 2
• Distinct Features of Gut Microbiota in High-Altitude Tibetan and Middle-Altitude Han Hypertensive Patients/Experiment 3
• Distinct Features of Gut Microbiota in High-Altitude Tibetan and Middle-Altitude Han Hypertensive Patients/Experiment 4
• Distinct Features of Gut Microbiota in High-Altitude Tibetan and Middle-Altitude Han Hypertensive Patients/Experiment 5
• Distinct Features of Gut Microbiota in High-Altitude Tibetan and Middle-Altitude Han Hypertensive Patients/Experiment 6
• Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19
• Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19/Experiment 1
• Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19/Experiment 2
• Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19/Experiment 3
• Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19/Experiment 4
• Alterations in Gastric Microbial Communities Are Associated with Risk of Gastric Cancer in a Korean Population: A Case-Control Study/Experiment 1
• Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19
• Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19/Experiment 1
• Association of high-risk human papillomavirus infection duration and cervical lesions with vaginal microbiota composition
• Association of high-risk human papillomavirus infection duration and cervical lesions with vaginal microbiota composition/Experiment 1
• Association of high-risk human papillomavirus infection duration and cervical lesions with vaginal microbiota composition/Experiment 1/Signature 1
• Association of high-risk human papillomavirus infection duration and cervical lesions with vaginal microbiota composition/Experiment 2
• Association of high-risk human papillomavirus infection duration and cervical lesions with vaginal microbiota composition/Experiment 3
• Association of high-risk human papillomavirus infection duration and cervical lesions with vaginal microbiota composition/Experiment 4
• Association of high-risk human papillomavirus infection duration and cervical lesions with vaginal microbiota composition/Experiment 5
• Association of high-risk human papillomavirus infection duration and cervical lesions with vaginal microbiota composition/Experiment 6
• Association of high-risk human papillomavirus infection duration and cervical lesions with vaginal microbiota composition/Experiment 7
• Association of high-risk human papillomavirus infection duration and cervical lesions with vaginal microbiota composition/Experiment 8
• Association of high-risk human papillomavirus infection duration and cervical lesions with vaginal microbiota composition/Experiment 9
• Depiction of Vaginal Microbiota in Women With High-Risk Human Papillomavirus Infection
• Depiction of Vaginal Microbiota in Women With High-Risk Human Papillomavirus Infection/Experiment 1
• Changes of vaginal microbiota during cervical carcinogenesis in women with human papillomavirus infection/Experiment 1
• High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin
• High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin/Experiment 1
• High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin/Experiment 2
• High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin/Experiment 3
• Characterization and Analysis of the Skin Microbiota in Rosacea: A Case-Control Study/Experiment 1
• Characterization and Analysis of the Skin Microbiota in Rosacea: A Case-Control Study/Experiment 2
• Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza
• Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza/Experiment 1
• Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza/Experiment 2
• Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza/Experiment 3
• Differential intestinal and oral microbiota features associated with gestational diabetes and maternal inflammation/Experiment 1
• Modulation of potential respiratory pathogens by pH1N1 viral infection
• Modulation of potential respiratory pathogens by pH1N1 viral infection/Experiment 1
• Characterization of the Oral Microbiome of Medicated Type-2 Diabetes Patients
• Characterization of the Oral Microbiome of Medicated Type-2 Diabetes Patients/Experiment 1
• The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort
• The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort/Experiment 1
• The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort/Experiment 2
• The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort/Experiment 3
• The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort/Experiment 4
• Subgingival Microbiota during Healthy Pregnancy and Pregnancy Gingivitis
• Subgingival Microbiota during Healthy Pregnancy and Pregnancy Gingivitis/Experiment 1
• Subgingival Microbiota during Healthy Pregnancy and Pregnancy Gingivitis/Experiment 2
• Alteration of salivary microbiome in periodontitis with or without type-2 diabetes mellitus and metformin treatment/Experiment 1
• Alteration of salivary microbiome in periodontitis with or without type-2 diabetes mellitus and metformin treatment/Experiment 2
• Alteration of salivary microbiome in periodontitis with or without type-2 diabetes mellitus and metformin treatment/Experiment 3
• Alteration of salivary microbiome in periodontitis with or without type-2 diabetes mellitus and metformin treatment/Experiment 4
• Alteration of salivary microbiome in periodontitis with or without type-2 diabetes mellitus and metformin treatment/Experiment 5
• Evaluation of superinfection, antimicrobial usage, and airway microbiome with metagenomic sequencing in COVID-19 patients: A cohort study in Shanghai
• Evaluation of superinfection, antimicrobial usage, and airway microbiome with metagenomic sequencing in COVID-19 patients: A cohort study in Shanghai/Experiment 1
• Evaluation of superinfection, antimicrobial usage, and airway microbiome with metagenomic sequencing in COVID-19 patients: A cohort study in Shanghai/Experiment 2
• Nasopharyngeal Microbiota in SARS-CoV-2 Positive and Negative Patients
• Nasopharyngeal Microbiota in SARS-CoV-2 Positive and Negative Patients/Experiment 1
• Nasopharyngeal Microbiota in SARS-CoV-2 Positive and Negative Patients/Experiment 1/Signature 1
• Alterations in the human oral and gut microbiomes and lipidomics in COVID-19
• Alterations in the human oral and gut microbiomes and lipidomics in COVID-19/Experiment 1
• Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study/Experiment 1/Signature 2
• Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study/Experiment 2
• Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study/Experiment 3
• Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study/Experiment 5
• Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study/Experiment 6
• Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study/Experiment 7
• Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study/Experiment 9
• Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study/Experiment 10
• Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19
• Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19/Experiment 1
• Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer
• Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer/Experiment 1
• Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation
• 16S rRNA gene amplicon sequencing of gut microbiota in gestational diabetes mellitus and their correlation with disease risk factors/Experiment 1
• Diversity and genomic determinants of the microbiomes associated with COVID-19 and non-COVID respiratory diseases
• Diversity and genomic determinants of the microbiomes associated with COVID-19 and non-COVID respiratory diseases/Experiment 1
• Diversity and genomic determinants of the microbiomes associated with COVID-19 and non-COVID respiratory diseases/Experiment 1/Signature 1
• Gut Microbiota May Not Be Fully Restored in Recovered COVID-19 Patients After 3-Month Recovery/Experiment 1
• Nasopharyngeal Microbial Communities of Patients Infected With SARS-CoV-2 That Developed COVID-19
• Nasopharyngeal Microbial Communities of Patients Infected With SARS-CoV-2 That Developed COVID-19/Experiment 1
• Nasopharyngeal Microbial Communities of Patients Infected With SARS-CoV-2 That Developed COVID-19/Experiment 2
• Nasopharyngeal Microbial Communities of Patients Infected With SARS-CoV-2 That Developed COVID-19/Experiment 3
• Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients
• Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients/Experiment 1
• Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients/Experiment 2
• Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
• Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization/Experiment 1
• Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization/Experiment 2
• Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization/Experiment 3
• Enriched Opportunistic Pathogens Revealed by Metagenomic Sequencing Hint Potential Linkages between Pharyngeal Microbiota and COVID-19
• Enriched Opportunistic Pathogens Revealed by Metagenomic Sequencing Hint Potential Linkages between Pharyngeal Microbiota and COVID-19/Experiment 1
• Enriched Opportunistic Pathogens Revealed by Metagenomic Sequencing Hint Potential Linkages between Pharyngeal Microbiota and COVID-19/Experiment 2
• Enriched Opportunistic Pathogens Revealed by Metagenomic Sequencing Hint Potential Linkages between Pharyngeal Microbiota and COVID-19/Experiment 3
• Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever
• Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever/Experiment 1
• Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever/Experiment 2
• Gut Dysbiosis and IL-21 Response in Patients with Severe COVID-19
• Gut Dysbiosis and IL-21 Response in Patients with Severe COVID-19/Experiment 1
• Gut Dysbiosis and IL-21 Response in Patients with Severe COVID-19/Experiment 1/Signature 2
• Gut Dysbiosis and IL-21 Response in Patients with Severe COVID-19/Experiment 2
• Gut Dysbiosis and IL-21 Response in Patients with Severe COVID-19/Experiment 3
• 16S rRNA gene sequencing of rectal swab in patients affected by COVID-19
• 16S rRNA gene sequencing of rectal swab in patients affected by COVID-19/Experiment 1
• 16S rRNA gene sequencing of rectal swab in patients affected by COVID-19/Experiment 2
• 16S rRNA gene sequencing of rectal swab in patients affected by COVID-19/Experiment 3
• Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy/Experiment 1
• Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18
• Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18/Experiment 1
• Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18/Experiment 2
• Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome
• Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome/Experiment 1
• Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome/Experiment 2
• Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome/Experiment 3
• Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome/Experiment 4
• Comparative analysis of racial differences in breast tumor microbiome
• Comparative analysis of racial differences in breast tumor microbiome/Experiment 1
• Comparative analysis of racial differences in breast tumor microbiome/Experiment 2
• Comparative analysis of racial differences in breast tumor microbiome/Experiment 3
• Comparative analysis of racial differences in breast tumor microbiome/Experiment 4
• Comparative analysis of racial differences in breast tumor microbiome/Experiment 5
• Comparative analysis of racial differences in breast tumor microbiome/Experiment 6
• Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients
• Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients/Experiment 1
• Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients/Experiment 1/Signature 2
• Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients/Experiment 2
• Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients/Experiment 3
• Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients/Experiment 4
• The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin
• The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin/Experiment 1
• The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin/Experiment 2
• Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients
• Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients/Experiment 1
• Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization
• Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization/Experiment 1
• Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization/Experiment 2
• Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization/Experiment 3
• Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization/Experiment 4
• Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization/Experiment 5
• Endometriosis induces gut microbiota alterations in mice
• Endometriosis induces gut microbiota alterations in mice/Experiment 1
• Endometriosis induces gut microbiota alterations in mice/Experiment 2
• Endometriosis induces gut microbiota alterations in mice/Experiment 2/Signature 1
• Endometriosis induces gut microbiota alterations in mice/Experiment 2/Signature 2
• Antibiotic therapy with metronidazole reduces endometriosis disease progression in mice: a potential role for gut microbiota/Experiment 1
• Altered Composition of Microbiota in Women with Ovarian Endometrioma: Microbiome Analyses of Extracellular Vesicles in the Peritoneal Fluid/Experiment 1
• Effect of endometriosis on the fecal bacteriota composition of mice during the acute phase of lesion formation/Experiment 1
• Variations in oral microbiome profiles in rheumatoid arthritis and osteoarthritis with potential biomarkers for arthritis screening
• Variations in oral microbiome profiles in rheumatoid arthritis and osteoarthritis with potential biomarkers for arthritis screening/Experiment 1
• Variations in oral microbiome profiles in rheumatoid arthritis and osteoarthritis with potential biomarkers for arthritis screening/Experiment 2
• Exercise Alters Gut Microbiota Composition and Function in Lean and Obese Humans/Experiment 1
• Exercise Alters Gut Microbiota Composition and Function in Lean and Obese Humans/Experiment 2
• Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism
• Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism/Experiment 1
• Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota/Experiment 1
• Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study/Experiment 1
• Dynamics of Gut Microbiota Recovery after Antibiotic Exposure in Young and Old Mice (A Pilot Study)/Experiment 1
• Dynamics of Gut Microbiota Recovery after Antibiotic Exposure in Young and Old Mice (A Pilot Study)/Experiment 2
• Dynamics of Gut Microbiota Recovery after Antibiotic Exposure in Young and Old Mice (A Pilot Study)/Experiment 3
• Dynamics of Gut Microbiota Recovery after Antibiotic Exposure in Young and Old Mice (A Pilot Study)/Experiment 4
• The association between vaginal bacterial composition and miscarriage: a nested case-control study
• The association between vaginal bacterial composition and miscarriage: a nested case-control study/Experiment 1
• The association between vaginal bacterial composition and miscarriage: a nested case-control study/Experiment 2
• The association between vaginal bacterial composition and miscarriage: a nested case-control study/Experiment 3
• Role of dietary fiber in the recovery of the human gut microbiome and its metabolome
• Gut Microbiome of Healthy and Arthritic Dogs/Experiment 1
• Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma/Experiment 1/Signature 1
• Alterations of the Predominant Fecal Microbiota and Disruption of the Gut Mucosal Barrier in Patients with Early-Stage Colorectal Cancer
• Alterations of the Predominant Fecal Microbiota and Disruption of the Gut Mucosal Barrier in Patients with Early-Stage Colorectal Cancer/Experiment 1
• Association of Gut Microbiome and Vitamin D Deficiency in Knee Osteoarthritis Patients: A Pilot Study
• Association of Gut Microbiome and Vitamin D Deficiency in Knee Osteoarthritis Patients: A Pilot Study/Experiment 1
• Association of Gut Microbiome and Vitamin D Deficiency in Knee Osteoarthritis Patients: A Pilot Study/Experiment 2
• Study of the Relationship between Microbiome and Colorectal Cancer Susceptibility Using 16SrRNA Sequencing
• Study of the Relationship between Microbiome and Colorectal Cancer Susceptibility Using 16SrRNA Sequencing/Experiment 1
• Antibiotics at birth and later antibiotic courses: effects on gut microbiota
• Sex effects in the association between airway microbiome and asthma/Experiment 1
• Sex effects in the association between airway microbiome and asthma/Experiment 2
• Alterations in Oral Microbiota in HIV Are Related to Decreased Pulmonary Function/Experiment 1
• Alterations in Oral Microbiota in HIV Are Related to Decreased Pulmonary Function/Experiment 2
• Alterations in Oral Microbiota in HIV Are Related to Decreased Pulmonary Function/Experiment 3
• Alterations in Oral Microbiota in HIV Are Related to Decreased Pulmonary Function/Experiment 3/Signature 1
• Altered composition of the gut microbiome in patients with drug-resistant epilepsy
• Altered composition of the gut microbiome in patients with drug-resistant epilepsy/Experiment 1
• Altered composition of the gut microbiome in patients with drug-resistant epilepsy/Experiment 2
• Integrative Analysis of Fecal Metagenomics and Metabolomics in Colorectal Cancer/Experiment 1
• Integrative Analysis of Fecal Metagenomics and Metabolomics in Colorectal Cancer/Experiment 2
• Preliminary Comparison of Oral and Intestinal Human Microbiota in Patients with Colorectal Cancer: A Pilot Study
• Evolution of the gut microbiome following acute HIV-1 infection/Experiment 1
• Oral microbiome in HIV-associated periodontitis/Experiment 1
• Alteration of the fecal microbiota in Chinese patients with Parkinson's disease/Experiment 1
• Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens/Experiment 1
• Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease
• Alteration of fecal tryptophan metabolism correlates with shifted microbiota and may be involved in pathogenesis of colorectal cancer
• Alteration of fecal tryptophan metabolism correlates with shifted microbiota and may be involved in pathogenesis of colorectal cancer/Experiment 1
• Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome/Experiment 1/Signature 3
• Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing/Experiment 1
• Comparison of Microbiota in Patients Treated by Surgery or Chemotherapy by 16S rRNA Sequencing Reveals Potential Biomarkers for Colorectal Cancer Therapy
• Comparison of Microbiota in Patients Treated by Surgery or Chemotherapy by 16S rRNA Sequencing Reveals Potential Biomarkers for Colorectal Cancer Therapy/Experiment 1
• Characteristics of fecal gut microbiota in patients with colorectal cancer at different stages and different sites
• Characteristics of fecal gut microbiota in patients with colorectal cancer at different stages and different sites/Experiment 1
• Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study
• Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study/Experiment 1
• Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study/Experiment 2
• Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study/Experiment 2/Signature 1
• Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study/Experiment 2/Signature 2
• Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study/Experiment 3
• Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study/Experiment 4
• Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns
• Microbiota profile is different for early and invasive colorectal cancer and is consistent throughout the colon/Experiment 1
• Randomised clinical study: oral aspirin 325 mg daily vs placebo alters gut microbial composition and bacterial taxa associated with colorectal cancer risk/Experiment 1
• Randomised clinical study: oral aspirin 325 mg daily vs placebo alters gut microbial composition and bacterial taxa associated with colorectal cancer risk/Experiment 2
• Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy/Experiment 1
• Fusobacterium nucleatum and T Cells in Colorectal Carcinoma/Experiment 1
• Gut microbiome development along the colorectal adenoma-carcinoma sequence/Experiment 1
• Gut microbiome development along the colorectal adenoma-carcinoma sequence/Experiment 2
• Gut microbiome development along the colorectal adenoma-carcinoma sequence/Experiment 3
• Differences in the Oral Microbiome in Patients With Early Rheumatoid Arthritis and Individuals at Risk of Rheumatoid Arthritis Compared to Healthy Individuals/Experiment 1
• Effect of ethnicity and socioeconomic variation to the gut microbiota composition among pre-adolescent in Malaysia/Experiment 1
• Dysbiosis of human gut microbiome in young-onset colorectal cancer/Experiment 1
• Dysbiosis of human gut microbiome in young-onset colorectal cancer/Experiment 1/Signature 1
• Dysbiosis of human gut microbiome in young-onset colorectal cancer/Experiment 2
• Associations Between Race, Perceived Psychological Stress, and the Gut Microbiota in a Sample of Generally Healthy Black and White Women: A Pilot Study on the Role of Race and Perceived Psychological Stress/Experiment 1
• Ethnicity influences the gut microbiota of individuals sharing a geographical location: a cross-sectional study from a middle-income country/Experiment 1
• Ethnicity influences the gut microbiota of individuals sharing a geographical location: a cross-sectional study from a middle-income country/Experiment 2
• Ethnicity influences the gut microbiota of individuals sharing a geographical location: a cross-sectional study from a middle-income country/Experiment 3
• Ethnicity influences the gut microbiota of individuals sharing a geographical location: a cross-sectional study from a middle-income country/Experiment 4
• Ethnicity influences the gut microbiota of individuals sharing a geographical location: a cross-sectional study from a middle-income country/Experiment 5
• Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab/Experiment 1
• Characterization of gut microbiota in patients with primary hepatocellular carcinoma received immune checkpoint inhibitors: A Chinese population-based study/Experiment 1
• Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States/Experiment 1
• Environmental exposures and child and maternal gut microbiota in rural Malawi/Experiment 1
• Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage/Experiment 1
• Altered Fecal Small RNA Profiles in Colorectal Cancer Reflect Gut Microbiome Composition in Stool Samples/Experiment 1
• A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer/Experiment 1
• A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer/Experiment 2
• Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients/Experiment 1
• Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients/Experiment 2
• Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients/Experiment 3
• Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 1
• Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 1/Signature 1
• Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 2
• Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 3
• Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 4
• Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 5
• Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 6
• Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 6/Signature 2